{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:16Z","timestamp":1791357436946,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Health and Labor Sciences Research","award":["19GC1012"],"award-info":[{"award-number":["19GC1012"]}]},{"name":"Eisai Co., Ltd.","award":["112\u20138088"],"award-info":[{"award-number":["112\u20138088"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpsychires.2020.05.025","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T09:28:58Z","timestamp":1590658138000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"128","author":[{"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Okuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychires.2020.05.025_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.117.241422","article-title":"In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist","volume":"362","author":"Beuckmann","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.jpsychires.2020.05.025_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr. Clin. Trials"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.05.025_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0976-500X.155496","article-title":"Suvorexant: the first orexin receptor antagonist to treat insomnia","volume":"6","author":"Dubey","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"2","key":"10.1016\/j.jpsychires.2020.05.025_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.025_bib5","author":"Higgins"},{"issue":"9","key":"10.1016\/j.jpsychires.2020.05.025_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/cn300086a","article-title":"ACS chemical neuroscience molecule spotlight on Suvorexant","volume":"3","author":"Hopkins","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.jpsychires.2020.05.025_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.5665\/SLEEP.1230","article-title":"Insomnia and the performance of US workers: results from the America insomnia survey","volume":"34","author":"Kessler","year":"2011","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.jpsychires.2020.05.025_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136910","article-title":"Suvorexant for primary insomnia: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"10","author":"Kishi","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2020.05.025_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.13011su1c","article-title":"Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system","volume":"74","author":"Krystal","year":"2013","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.025_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/NSS.S6846","article-title":"Critical appraisal of ramelteon in the treatment of insomnia","volume":"2","author":"Mets","year":"2010","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.jpsychires.2020.05.025_bib11","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2020.05.025_bib12","author":"NCT02952820"},{"issue":"7","key":"10.1016\/j.jpsychires.2020.05.025_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/sleep\/30.7.873","article-title":"Chronic insomnia as a risk factor for developing anxiety and depression","volume":"30","author":"Neckelmann","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.jpsychires.2020.05.025_bib14","author":"R\u00fccker"},{"issue":"4","key":"10.1016\/j.jpsychires.2020.05.025_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jrsm.1193","article-title":"Empirical evidence about inconsistency among studies in a pair-wise meta-analysis","volume":"7","author":"Rhodes","year":"2016","journal-title":"Res. Synth. Methods"},{"issue":"4","key":"10.1016\/j.jpsychires.2020.05.025_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","article-title":"Insomnia pharmacotherapy","volume":"9","author":"Roehrs","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.jpsychires.2020.05.025_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5 Suppl. l","key":"10.1016\/j.jpsychires.2020.05.025_bib18","first-page":"S7","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.jpsychires.2020.05.025_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jpsychires.2020.05.025_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.05.025_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.jpsychires.2020.05.025_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.jpsychires.2020.05.025_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"issue":"23","key":"10.1016\/j.jpsychires.2020.05.025_bib24","doi-asserted-by":"crossref","first-page":"e2110","DOI":"10.1212\/WNL.0000000000008581","article-title":"Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort","volume":"93","author":"Zheng","year":"2019","journal-title":"Neurology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620304908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620304908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:15:38Z","timestamp":1758366938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395620304908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"alternative-id":["S0022395620304908"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.05.025","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}